{"id":"W4414857438","doi":"10.1093/oncolo/oyaf330","title":"Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study","year":2025,"lang":"en","type":"article","venue":"The Oncologist","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"Daiichi Sankyo Europe; U.S. Food and Drug Administration; Celgene; MorphoSys; Gilead Sciences; Kite Pharma; Incyte; BeiGene; TG Therapeutics; Seagen; Karyopharm Therapeutics; AstraZeneca","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Lymphoma; Standard of care; Salvage therapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000928055,0.0007840156,0.0007973504,0.001237334,0.002249462,0.00103238,0.001623631,0.0005412506,0.00145136],"category_scores_gemma":[0.001826622,0.0004373315,0.00111497,0.004134549,0.0006298964,0.0003390829,0.001073374,0.0007565648,0.000217958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0258479,"about_ca_system_score_gemma":0.02577343,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9481345,"about_ca_topic_score_gemma":0.9684781,"domain_scores_codex":[0.9986116,0.0001214665,0.00008801065,0.0002847499,0.0004150572,0.0004791241],"domain_scores_gemma":[0.9977177,0.0001126389,0.000804928,0.0001571544,0.0007362979,0.000471201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008189631,0.0001182094,0.9924777,0.00009986175,0.000305449,0.0001614634,0.0003374279,0.0001511876,0.000319692,0.00008220947,0.001715387,0.0034124],"study_design_scores_gemma":[0.0001328028,0.000173017,0.9964142,0.00003985996,0.0001555883,0.0002072683,0.0006930458,0.0002079271,0.00008082014,0.00002013387,0.00185275,0.00002250918],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904497,0.000680359,0.00006110823,0.0001767074,0.00001164067,0.0001373258,0.007351157,0.000007866767,0.001123986],"genre_scores_gemma":[0.9885771,0.0006596424,0.0002253241,0.0003461418,0.00002691815,0.00009972753,0.009607273,0.00000837269,0.0004494275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05186546,"threshold_uncertainty_score":0.1875405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02572095470819502,"score_gpt":0.3219684897978651,"score_spread":0.2962475350896701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}